Women's perspectives on the acceptability and feasibility of an HPV screen-and-treat approach to cervical cancer prevention in Iquitos, Peru: a qualitative study.
AuthorMorse, Rachel M
Noble, Helen E
Ríos López, E Jennifer
Del Cuadro, Daniel Lenin
Gonzales Díaz, Karina
Figueredo Escudero, Magaly
Vásquez Del Aguila, Giannina
Carrillo Jara, Lita E
Silva Delgado, Hermann F
Palacios, Victor A
Gravitt, Patti E
Paz-Soldan, Valerie A
JournalBMC women's health
MetadataShow full item record
AbstractBackground: The objective of this study was to explore women's experiences of a screen-and-treat approach with ablative therapy (referred to by the Spanish acronym TVT-TA) as a method of treatment following a positive HPV test in Iquitos, Peru. Methods: A total of 111 in-depth interviews were conducted with 47 HPV positive women who attended the TVT-TA procedure at a primary-level healthcare facility. Interviews were conducted immediately before, immediately after, and six-weeks after TVT-TA. Results: Most interviewed women reported experiencing moderate pain during ablative therapy and minimal pain immediately after and six weeks after ablative therapy. Women also stated that the pain was less intense than they had expected. The most common physical after-effects of treatment were bleeding and vaginal odor. Women experienced oscillating emotions with fear upon receiving a positive HPV result, calming after hearing about ablative therapy treatment, worry about pain from the treatment itself, relaxation with counseling about the procedure, and relief following treatment. Conclusions: Nearly all participants emphasized that they were pleased with the TVT-TA process even if they had experienced pain during TVT-TA, recommended that TVT-TA be expanded and available to more women, and stated that TVT-TA was faster and easier than expected. This study found that TVT-TA is a feasible and acceptable means of treating HPV according to the women receiving the treatment.
Rights/Terms© 2022. The Author(s).
Identifier to cite or link to this itemhttp://hdl.handle.net/10713/20000
- Acceptability and Feasibility of HPV Self-Sampling as an Alternative Primary Cervical Cancer Screening in Under-Screened Population Groups: A Cross-Sectional Study.
- Authors: Wong EL, Cheung AW, Wong AY, Chan PK
- Issue date: 2020 Aug 27
- The Peru Cervical Cancer Prevention Study (PERCAPS): the technology to make screening accessible.
- Authors: Levinson KL, Abuelo C, Salmeron J, Chyung E, Zou J, Belinson SE, Wang G, Ortiz CS, Vallejos CS, Belinson JL
- Issue date: 2013 May
- "The best thing is that you are doing it for yourself" - perspectives on acceptability and feasibility of HPV self-sampling among cervical cancer screening clients in Tanzania: a qualitative pilot study.
- Authors: Bakiewicz A, Rasch V, Mwaiselage J, Linde DS
- Issue date: 2020 Mar 31
- Feasibility, validity and acceptability of self-collected samples for human papillomavirus (HPV) testing in rural Malawi.
- Authors: Esber A, Norris A, Jumbe E, Kandodo J, Nampandeni P, Reese PC, Turner AN
- Issue date: 2018 Jun
- Feasibility of a community-based cervical cancer screening with "test and treat" strategy using self-sample for an HPV test: Experience from rural Cameroon, Africa.
- Authors: Fokom Domgue J, Futuh B, Ngalla C, Kakute P, Manjuh F, Manga S, Nulah K, Welty E, Schmeler K, Welty T
- Issue date: 2020 Jul 1